Bilal Chughtai, MD, Assistant Professor of Urology, Weill Cornell Medical College, New York, who will study the systematic response of polypropylene mesh implantation in women. It has been reported on consumer and patient group websites that those individuals who experienced adverse reactions to transvaginal mesh repairs are receiving subsequent diagnoses of autoimmune disorders such as lupus, fibromyalgia and rheumatoid arthritis, however, there has been no specific clinical study conducted to confirm this association. Dr. Chughtai aims to focus his efforts in this area.

Michael Ordon, MD, MSc, FRSC, Division of Urology, Department of Surgery, St. Michael's Hospital, University of Toronto, Toronto, Canada and Blayne Welk, MD, FRCSC, MSc, Assistant Professor, Western University, London, Ontario and Adjunct Scientist, Institute for Clinical Evaluative Sciences, St. Joseph's Hospital, Ontario, Canada, who will collaboratively evaluate the impact of the urology-based Choosing Wisely&reg, recommendations on low value medical care,that is, common tests and procedures frequently overused or misused,in both the United States and Canada. Aimed at ensuring high-quality, cost-effective care for patients, the Choosing Wisely campaign centers on tests and procedures providers and patients should discuss and carefully consider before incorporating them into a treatment plan. Both Dr. Ordon and Dr. Welk plan to assess the impact these recommendations on the cost of care.

Vemulakonda Vijay, MD, JD, Assistant Professor, Pediatric Surgery, The Children',s Hospital, University of Colorado Denver School of Medicine, Denver, CO, whose project aims to develop an Electronic Medical Records (EMR)-based pediatric urology research network to assess current Vesicoureteral Reflux (VUR) treatment patterns.Data collected from this study will be used to define current practice patterns, expand the developed research network and strengthen adherence to current published VUR guidelines.

Alan Kaplan, MD, Resident Department of Urology, UCLA will analyze the substantial treatment and cost variation in benign prostatic hyperplasia (BPH) surgery through defined value-based care pathway for BPH using clinical outcomes, guidelines, cost and patient experience. Results collected from this study will determine if data can change practice patterns and whether outcomes and costs are affected. A care redesign playbook for physician practices and provider organizations showing transition to care models that prioritize value will also result from this study.